MP32-17 “CHOOSING WISELY” – PROSTATE CANCER SCREENING, DIAGNOSIS, AND TREATMENT AMONG THE ELDERLY MEN IN ISRAEL Academic Article uri icon

abstract

  • METHODS This is a population-based cohort study, using Clalit electronic-databases. Clalit is the largest HMO in Israel and insures over 4,000,000 subjects. Our cohort included all 220,861 Clalit male patients who were 75 or older in January 1st 2009. We recorded all PSA tests, diagnostic biopsies, and treatments for early-stage prostate-cancer, between the years 2009-2013. We performed a uni and multivariable analyses to determine patient and doctor related variables that were associated with PSA testing among elderly patients. RESULTS Excluding patients who had a prior prostate-cancer diagnosis our final cohort included 213,814 subjects. During the study period, 187,228 PSA tests were performed on 55,886 subjects (26.1%). The median PSA was 2.15 ng/ml (IQR 0.92, 4.7). PSA tests were common even among subjects older than 85, with 10,594 of 79,731 subjects tested (13.3%) …

publication date

  • January 1, 2015